BELRAPZO
bendamustine hydrochloride
- Strength
- 100 mg/4mL
- Form
- Injection
- Class
- Alkylating Drug
Eagle Pharmaceuticals, Inc
Not stocked by us — reference only
Listed by Baxter Healthcare Corporation
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | Alkylating Drug |
| Approval route | NDA — original brand approval |
| NDC code | 10019-079 |
| FDA application | NDA216078 |
| RxNorm concept | 1726097 |
| Package sizes listed | 1 |
| Marketed since | December 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
bendamustine hydrochloride
Eagle Pharmaceuticals, Inc
Not stocked by us — reference only
bendamustine HCl
Meitheal Pharmaceuticals Inc.
Not stocked by us — reference only
Bendamustine HCl
Meitheal Pharmaceuticals Inc.
Not stocked by us — reference only
Accord Healthcare, Inc.
Not stocked by us — reference only
BluePoint Laboratories
Not stocked by us — reference only
Avyxa Pharma, LLC
Not stocked by us — reference only
Eugia US LLC
Not stocked by us — reference only
Accord Healthcare, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.